COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries

Widespread acceptance of COVID-19 vaccines is crucial for achieving sufficient immunization coverage to end the global pandemic, yet few studies have investigated COVID-19 vaccination attitudes in lower-income countries, where large-scale vaccination is just beginning. We analyze COVID-19 vaccine ac...

Full description

Bibliographic Details
Main Authors: Solís Arce, JS, Warren, SS, Meriggi, NF, Scacco, A, McMurry, N, Voors, M, Syunyaev, G, Malik, AA, Aboutajdine, S, Adeojo, O, Anigo, D, Armand, A, Asad, S, Atyera, M, Augsburg, B, Awasthi, M, Ayesiga, GE, Bancalari, A, Björkman Nyqvist, M, Borisova, E, Bosancianu, CM, Cabra García, MR, Cheema, A, Collins, E, Cuccaro, F, Farooqi, AZ, Fatima, T, Fracchia, M, Galindo Soria, ML, Guariso, A, Hasanain, A, Jaramillo, S, Kallon, S, Kamwesigye, A, Kharel, A, Kreps, S, Levine, M, Littman, R, Malik, M, Manirabaruta, G, Mfura, JLH, Momoh, F, Mucauque, A, Mussa, I, Nsabimana, JA, Obara, I, Otálora, MJ, Ouédraogo, BW, Pare, TB, Platas, MR
Format: Journal article
Language:English
Published: Springer Nature 2021
_version_ 1797112228204249088
author Solís Arce, JS
Warren, SS
Meriggi, NF
Scacco, A
McMurry, N
Voors, M
Syunyaev, G
Malik, AA
Aboutajdine, S
Adeojo, O
Anigo, D
Armand, A
Asad, S
Atyera, M
Augsburg, B
Awasthi, M
Ayesiga, GE
Bancalari, A
Björkman Nyqvist, M
Borisova, E
Bosancianu, CM
Cabra García, MR
Cheema, A
Collins, E
Cuccaro, F
Farooqi, AZ
Fatima, T
Fracchia, M
Galindo Soria, ML
Guariso, A
Hasanain, A
Jaramillo, S
Kallon, S
Kamwesigye, A
Kharel, A
Kreps, S
Levine, M
Littman, R
Malik, M
Manirabaruta, G
Mfura, JLH
Momoh, F
Mucauque, A
Mussa, I
Nsabimana, JA
Obara, I
Otálora, MJ
Ouédraogo, BW
Pare, TB
Platas, MR
author_facet Solís Arce, JS
Warren, SS
Meriggi, NF
Scacco, A
McMurry, N
Voors, M
Syunyaev, G
Malik, AA
Aboutajdine, S
Adeojo, O
Anigo, D
Armand, A
Asad, S
Atyera, M
Augsburg, B
Awasthi, M
Ayesiga, GE
Bancalari, A
Björkman Nyqvist, M
Borisova, E
Bosancianu, CM
Cabra García, MR
Cheema, A
Collins, E
Cuccaro, F
Farooqi, AZ
Fatima, T
Fracchia, M
Galindo Soria, ML
Guariso, A
Hasanain, A
Jaramillo, S
Kallon, S
Kamwesigye, A
Kharel, A
Kreps, S
Levine, M
Littman, R
Malik, M
Manirabaruta, G
Mfura, JLH
Momoh, F
Mucauque, A
Mussa, I
Nsabimana, JA
Obara, I
Otálora, MJ
Ouédraogo, BW
Pare, TB
Platas, MR
author_sort Solís Arce, JS
collection OXFORD
description Widespread acceptance of COVID-19 vaccines is crucial for achieving sufficient immunization coverage to end the global pandemic, yet few studies have investigated COVID-19 vaccination attitudes in lower-income countries, where large-scale vaccination is just beginning. We analyze COVID-19 vaccine acceptance across 15 survey samples covering 10 low- and middle-income countries (LMICs) in Asia, Africa and South America, Russia (an upper-middle-income country) and the United States, including a total of 44,260 individuals. We find considerably higher willingness to take a COVID-19 vaccine in our LMIC samples (mean 80.3%; median 78%; range 30.1 percentage points) compared with the United States (mean 64.6%) and Russia (mean 30.4%). Vaccine acceptance in LMICs is primarily explained by an interest in personal protection against COVID-19, while concern about side effects is the most common reason for hesitancy. Health workers are the most trusted sources of guidance about COVID-19 vaccines. Evidence from this sample of LMICs suggests that prioritizing vaccine distribution to the Global South should yield high returns in advancing global immunization coverage. Vaccination campaigns should focus on translating the high levels of stated acceptance into actual uptake. Messages highlighting vaccine efficacy and safety, delivered by healthcare workers, could be effective for addressing any remaining hesitancy in the analyzed LMICs.
first_indexed 2024-03-07T08:22:43Z
format Journal article
id oxford-uuid:1de69f69-0432-49ca-92d1-b527372b171f
institution University of Oxford
language English
last_indexed 2024-03-07T08:22:43Z
publishDate 2021
publisher Springer Nature
record_format dspace
spelling oxford-uuid:1de69f69-0432-49ca-92d1-b527372b171f2024-02-06T06:16:41ZCOVID-19 vaccine acceptance and hesitancy in low- and middle-income countriesJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:1de69f69-0432-49ca-92d1-b527372b171fEnglishSymplectic ElementsSpringer Nature2021Solís Arce, JSWarren, SSMeriggi, NFScacco, AMcMurry, NVoors, MSyunyaev, GMalik, AAAboutajdine, SAdeojo, OAnigo, DArmand, AAsad, SAtyera, MAugsburg, BAwasthi, MAyesiga, GEBancalari, ABjörkman Nyqvist, MBorisova, EBosancianu, CMCabra García, MRCheema, ACollins, ECuccaro, FFarooqi, AZFatima, TFracchia, MGalindo Soria, MLGuariso, AHasanain, AJaramillo, SKallon, SKamwesigye, AKharel, AKreps, SLevine, MLittman, RMalik, MManirabaruta, GMfura, JLHMomoh, FMucauque, AMussa, INsabimana, JAObara, IOtálora, MJOuédraogo, BWPare, TBPlatas, MRWidespread acceptance of COVID-19 vaccines is crucial for achieving sufficient immunization coverage to end the global pandemic, yet few studies have investigated COVID-19 vaccination attitudes in lower-income countries, where large-scale vaccination is just beginning. We analyze COVID-19 vaccine acceptance across 15 survey samples covering 10 low- and middle-income countries (LMICs) in Asia, Africa and South America, Russia (an upper-middle-income country) and the United States, including a total of 44,260 individuals. We find considerably higher willingness to take a COVID-19 vaccine in our LMIC samples (mean 80.3%; median 78%; range 30.1 percentage points) compared with the United States (mean 64.6%) and Russia (mean 30.4%). Vaccine acceptance in LMICs is primarily explained by an interest in personal protection against COVID-19, while concern about side effects is the most common reason for hesitancy. Health workers are the most trusted sources of guidance about COVID-19 vaccines. Evidence from this sample of LMICs suggests that prioritizing vaccine distribution to the Global South should yield high returns in advancing global immunization coverage. Vaccination campaigns should focus on translating the high levels of stated acceptance into actual uptake. Messages highlighting vaccine efficacy and safety, delivered by healthcare workers, could be effective for addressing any remaining hesitancy in the analyzed LMICs.
spellingShingle Solís Arce, JS
Warren, SS
Meriggi, NF
Scacco, A
McMurry, N
Voors, M
Syunyaev, G
Malik, AA
Aboutajdine, S
Adeojo, O
Anigo, D
Armand, A
Asad, S
Atyera, M
Augsburg, B
Awasthi, M
Ayesiga, GE
Bancalari, A
Björkman Nyqvist, M
Borisova, E
Bosancianu, CM
Cabra García, MR
Cheema, A
Collins, E
Cuccaro, F
Farooqi, AZ
Fatima, T
Fracchia, M
Galindo Soria, ML
Guariso, A
Hasanain, A
Jaramillo, S
Kallon, S
Kamwesigye, A
Kharel, A
Kreps, S
Levine, M
Littman, R
Malik, M
Manirabaruta, G
Mfura, JLH
Momoh, F
Mucauque, A
Mussa, I
Nsabimana, JA
Obara, I
Otálora, MJ
Ouédraogo, BW
Pare, TB
Platas, MR
COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries
title COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries
title_full COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries
title_fullStr COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries
title_full_unstemmed COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries
title_short COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries
title_sort covid 19 vaccine acceptance and hesitancy in low and middle income countries
work_keys_str_mv AT solisarcejs covid19vaccineacceptanceandhesitancyinlowandmiddleincomecountries
AT warrenss covid19vaccineacceptanceandhesitancyinlowandmiddleincomecountries
AT merigginf covid19vaccineacceptanceandhesitancyinlowandmiddleincomecountries
AT scaccoa covid19vaccineacceptanceandhesitancyinlowandmiddleincomecountries
AT mcmurryn covid19vaccineacceptanceandhesitancyinlowandmiddleincomecountries
AT voorsm covid19vaccineacceptanceandhesitancyinlowandmiddleincomecountries
AT syunyaevg covid19vaccineacceptanceandhesitancyinlowandmiddleincomecountries
AT malikaa covid19vaccineacceptanceandhesitancyinlowandmiddleincomecountries
AT aboutajdines covid19vaccineacceptanceandhesitancyinlowandmiddleincomecountries
AT adeojoo covid19vaccineacceptanceandhesitancyinlowandmiddleincomecountries
AT anigod covid19vaccineacceptanceandhesitancyinlowandmiddleincomecountries
AT armanda covid19vaccineacceptanceandhesitancyinlowandmiddleincomecountries
AT asads covid19vaccineacceptanceandhesitancyinlowandmiddleincomecountries
AT atyeram covid19vaccineacceptanceandhesitancyinlowandmiddleincomecountries
AT augsburgb covid19vaccineacceptanceandhesitancyinlowandmiddleincomecountries
AT awasthim covid19vaccineacceptanceandhesitancyinlowandmiddleincomecountries
AT ayesigage covid19vaccineacceptanceandhesitancyinlowandmiddleincomecountries
AT bancalaria covid19vaccineacceptanceandhesitancyinlowandmiddleincomecountries
AT bjorkmannyqvistm covid19vaccineacceptanceandhesitancyinlowandmiddleincomecountries
AT borisovae covid19vaccineacceptanceandhesitancyinlowandmiddleincomecountries
AT bosancianucm covid19vaccineacceptanceandhesitancyinlowandmiddleincomecountries
AT cabragarciamr covid19vaccineacceptanceandhesitancyinlowandmiddleincomecountries
AT cheemaa covid19vaccineacceptanceandhesitancyinlowandmiddleincomecountries
AT collinse covid19vaccineacceptanceandhesitancyinlowandmiddleincomecountries
AT cuccarof covid19vaccineacceptanceandhesitancyinlowandmiddleincomecountries
AT farooqiaz covid19vaccineacceptanceandhesitancyinlowandmiddleincomecountries
AT fatimat covid19vaccineacceptanceandhesitancyinlowandmiddleincomecountries
AT fracchiam covid19vaccineacceptanceandhesitancyinlowandmiddleincomecountries
AT galindosoriaml covid19vaccineacceptanceandhesitancyinlowandmiddleincomecountries
AT guarisoa covid19vaccineacceptanceandhesitancyinlowandmiddleincomecountries
AT hasanaina covid19vaccineacceptanceandhesitancyinlowandmiddleincomecountries
AT jaramillos covid19vaccineacceptanceandhesitancyinlowandmiddleincomecountries
AT kallons covid19vaccineacceptanceandhesitancyinlowandmiddleincomecountries
AT kamwesigyea covid19vaccineacceptanceandhesitancyinlowandmiddleincomecountries
AT kharela covid19vaccineacceptanceandhesitancyinlowandmiddleincomecountries
AT krepss covid19vaccineacceptanceandhesitancyinlowandmiddleincomecountries
AT levinem covid19vaccineacceptanceandhesitancyinlowandmiddleincomecountries
AT littmanr covid19vaccineacceptanceandhesitancyinlowandmiddleincomecountries
AT malikm covid19vaccineacceptanceandhesitancyinlowandmiddleincomecountries
AT manirabarutag covid19vaccineacceptanceandhesitancyinlowandmiddleincomecountries
AT mfurajlh covid19vaccineacceptanceandhesitancyinlowandmiddleincomecountries
AT momohf covid19vaccineacceptanceandhesitancyinlowandmiddleincomecountries
AT mucauquea covid19vaccineacceptanceandhesitancyinlowandmiddleincomecountries
AT mussai covid19vaccineacceptanceandhesitancyinlowandmiddleincomecountries
AT nsabimanaja covid19vaccineacceptanceandhesitancyinlowandmiddleincomecountries
AT obarai covid19vaccineacceptanceandhesitancyinlowandmiddleincomecountries
AT otaloramj covid19vaccineacceptanceandhesitancyinlowandmiddleincomecountries
AT ouedraogobw covid19vaccineacceptanceandhesitancyinlowandmiddleincomecountries
AT paretb covid19vaccineacceptanceandhesitancyinlowandmiddleincomecountries
AT platasmr covid19vaccineacceptanceandhesitancyinlowandmiddleincomecountries